Single-CpG-resolution methylome analysis identifies clinicopathologically aggressive CpG island methylator phenotype clear cell renal cell carcinomas.
about
Epigenomics of clear cell renal cell carcinoma: mechanisms and potential use in molecular pathologyHistone deacetylase inhibitors and epigenetic modifications as a novel strategy in renal cell carcinomaDNA methylation changes in epithelial ovarian cancer histotypes.The Emergence of Pan-Cancer CIMP and Its Elusive InterpretationEpigenomic characterization of locally advanced anal cancer: a radiation therapy oncology group 98-11 specimen studyA CpG island methylator phenotype of colorectal cancer that is contiguous with conventional adenomas, but not serrated polyps.Prognostication of patients with clear cell renal cell carcinomas based on quantification of DNA methylation levels of CpG island methylator phenotype marker genesAlterations of the WNT7A gene in clear cell renal cell carcinomasMultilayer-omics analysis of renal cell carcinoma, including the whole exome, methylome and transcriptome.Proteomic profile and in silico analysis in metastatic melanoma with and without BRAF mutationEpigenetic clustering of lung adenocarcinomas based on DNA methylation profiles in adjacent lung tissue: Its correlation with smoking history and chronic obstructive pulmonary diseaseDNA methylation profiling reveals novel diagnostic biomarkers in renal cell carcinoma.Genome-wide promoter methylome of small renal masses.A promising DNA methylation signature for the triage of high-risk human papillomavirus DNA-positive womenLong-range epigenetic regulation is conferred by genetic variation located at thousands of independent lociSLC13A5 is a novel transcriptional target of the pregnane X receptor and sensitizes drug-induced steatosis in human liver.Epigenetic clustering of gastric carcinomas based on DNA methylation profiles at the precancerous stage: its correlation with tumor aggressiveness and patient outcome.Clinical Implications and Prognostic Values of Prostate Cancer Susceptibility Candidate Methylation in Primary Nonmuscle Invasive Bladder Cancer.Pancreatic cancer patient survival correlates with DNA methylation of pancreas development genes.Comparative Correlation Structure of Colon Cancer Locus Specific Methylation: Characterisation of Patient Profiles and Potential Markers across 3 Array-Based Datasets.Prognostic implication of PTPRH hypomethylation in non-small cell lung cancer.eFORGE: A Tool for Identifying Cell Type-Specific Signal in Epigenomic Data.Identification of endometrial cancer methylation features using combined methylation analysis methods.Analysis of the molecular features of rectal carcinoid tumors to identify new biomarkers that predict biological malignancy.Methylomics analysis identifies ZNF671 as an epigenetically repressed novel tumor suppressor and a potential non-invasive biomarker for the detection of urothelial carcinoma.Alterations of the spindle checkpoint pathway in clinicopathologically aggressive CpG island methylator phenotype clear cell renal cell carcinomas.DNA methylation profiles at precancerous stages associated with recurrence of lung adenocarcinoma.A CpG-methylation-based assay to predict survival in clear cell renal cell carcinoma.Reduced Representation Bisulfite Sequencing Determination of Distinctive DNA Hypermethylated Genes in the Progression to Colon Cancer in African AmericansDistinct patterns of DNA methylation in conventional adenomas involving the right and left colon.Multilayer-omics analyses of human cancers: exploration of biomarkers and drug targets based on the activities of the International Human Epigenome Consortium.Recurrent patterns of DNA methylation in the ZNF154, CASP8, and VHL promoters across a wide spectrum of human solid epithelial tumors and cancer cell lines.Integrated analysis of genome-wide DNA methylation and gene expression profiles identifies potential novel biomarkers of rectal cancer.Genes involved in development and differentiation are commonly methylated in cancers derived from multiple organs: a single-institutional methylome analysis using 1007 tissue specimens.MicroRNA-196b is an independent prognostic biomarker in patients with pancreatic cancer.Survival differences of CIMP subtypes integrated with CNA information in human breast cancer.Loss of KCNQ1 expression in stage II and stage III colon cancer is a strong prognostic factor for disease recurrence.Alcohol and Dietary Folate Intake and Promoter CpG Island Methylation in Clear-Cell Renal Cell Cancer.DNA methylation status defines clinicopathological parameters including survival for patients with clear cell renal cell carcinoma (ccRCC).Epigenome Aberrations: Emerging Driving Factors of the Clear Cell Renal Cell Carcinoma.
P2860
Q26752925-A282ED26-F2C3-4F16-836D-DF5227BB060FQ27025984-EA931534-D59D-48F1-804C-17D02EED686CQ27690722-05347D79-6406-458C-ABFC-F8F3F9940824Q28075374-4C37E00F-DDBA-486C-AE18-F36842EBC876Q28390359-3CCE7989-72D6-4F59-B952-57FE3DEAD7F6Q34293192-F143D2B1-EB9E-4D2F-BD6C-1CC945B3DADBQ34438914-866AA64B-FDCC-4429-82CF-E1CBC7E057A2Q34442670-2A7C8FA1-0BBB-4619-B866-75802F8B2990Q34530994-E7F3046A-D471-49C0-863C-9CFB4A95658BQ34599527-99D042BB-A14F-4252-9D54-06AC31F5777DQ34629271-41597504-DD61-42F3-B3B0-7F2C51F88C08Q34694198-0527C1B2-696C-4DBF-AFCE-61D06351DE9DQ35035170-E91EBCAB-9602-425B-82AF-03F96166F509Q35125113-25D7CCE6-84CE-4719-B1DE-7C660F31DE61Q35153463-25CAADF3-51D5-4129-97ED-7115ED6E1894Q35198043-C4C1D91C-808A-431C-9837-5F6790569C1BQ35562690-289AD172-460C-4D8A-8FC6-1994D71A0C28Q35649706-9B163B6A-E734-4996-98FF-B2591D791947Q35651346-5ED50C0F-BD8B-4842-8477-9AA4571405F2Q35856869-F7FB26AA-566F-45CA-AC58-CAF2037968FAQ35934571-4E64F04B-CEBF-4BAD-9D75-FE595747421DQ36194281-C981036B-5438-40D7-B88A-44EA1B06300FQ36302529-06B518C6-2826-46E0-9BF5-118E89537549Q36355891-F4039691-3CFD-4BA5-9C2A-E6672BBF4157Q36557362-45649073-261B-435E-9960-188412932205Q36584397-FAB45A0C-F822-42FA-B60C-2193A067C8D9Q36721411-8B02ABB2-4E0E-4A1B-9167-84D827181265Q36839476-3A369DE2-1A8C-4E66-8082-9627B58A2013Q37256765-083FD9EB-03A0-4A10-9CD4-7884ACD194B2Q37432567-7887600B-D2DE-45C0-98FD-4316AB4E54A9Q37583117-185C14BF-1322-4DDD-A5E5-B11FC07E8538Q37600922-BCCCFBBC-7858-4337-ABEA-742EBFC5DF67Q37641812-B4225352-7F81-4A49-8B35-13919224E44FQ38438270-DB77DB4F-4BB3-4763-893B-2EF5247B40D0Q38716962-F9143493-7348-44A2-B84C-4743F1729BF0Q38834039-5C4ED3A1-84FB-4272-8208-B3A19A4C3CBAQ39180723-844D3379-CC4D-4141-BEF5-7BBD6C91C915Q40683675-AC2B67B0-FDD2-4BCB-8351-B77BD5840415Q40937833-0554EE42-6F75-41F3-AC64-E3BBFC2C67FEQ41574276-EF2726B9-9FE4-49FB-8A70-36C38B9CB3D4
P2860
Single-CpG-resolution methylome analysis identifies clinicopathologically aggressive CpG island methylator phenotype clear cell renal cell carcinomas.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Single-CpG-resolution methylom ...... ar cell renal cell carcinomas.
@ast
Single-CpG-resolution methylom ...... ar cell renal cell carcinomas.
@en
type
label
Single-CpG-resolution methylom ...... ar cell renal cell carcinomas.
@ast
Single-CpG-resolution methylom ...... ar cell renal cell carcinomas.
@en
prefLabel
Single-CpG-resolution methylom ...... ar cell renal cell carcinomas.
@ast
Single-CpG-resolution methylom ...... ar cell renal cell carcinomas.
@en
P2093
P2860
P356
P1433
P1476
Single-CpG-resolution methylom ...... ar cell renal cell carcinomas.
@en
P2093
Hiroyuki Fujimoto
Masahiro Gotoh
Suenori Chiku
Taisuke Mori
Tohru Nakagawa
P2860
P304
P356
10.1093/CARCIN/BGS177
P407
P577
2012-05-18T00:00:00Z